Design and Development of Nanovaccines: Platforms, Immunological Mechanisms, and Therapeutic Applications in Infectious Diseases, Cancer, and Tolerance Induction Approaches
Design and Development of Nanovaccines: Platforms, Immunological Mechanisms, and Therapeutic Applications in Infectious Diseases, Cancer, and Tolerance Induction Approaches
Fateme Bagherei1
1) M.Sc. in Chemical Engineering - Biotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran
IOI Code
:
ABGG-ABHHKF
Publication :
11th.International Conference on Researches in Science & Engineering & 8th.International Congress on Civil, Architecture and Urbanism in Asia(11icrsie.ir)
Abstract :
In recent years, the emergence of nanotechnology has revolutionized the design and development of vaccine delivery systems. Nanovaccines have emerged as efficient alternatives to traditional vaccines due to their ability to enhance antigen stability, precisely target immune cells, and induce robust, durable immune responses. This review article provides a comprehensive analysis of various nanoparticle platforms, including lipid, polymeric, metallic, and protein-based nanoparticles, and investigates their immunological mechanisms, such as antigen uptake by dendritic cells and the activation of signaling pathways. Furthermore, the therapeutic applications of nanovaccines in preventing and treating infectious diseases, as well as their innovative role in cancer immunotherapy—with a focus on inducing anti-tumor responses—are explored. A key aspect of this research is the investigation of immune tolerance induction approaches by nanovaccines for the treatment of autoimmune diseases and the prevention of transplant rejection, which charts a new horizon in modern medicine. Finally, challenges related to production scalability, long-term stability, and the biosafety of nanoparticles are discussed, and future pathways for the transition from laboratory research to clinical applications are outlined.
Keywords : nanovaccine immunotherapy drug delivery systems infectious diseases cancer immune tolerance